N/A
Manufactured by AARNA USA INC.
2 FDA adverse event reports analyzed
Last updated: 2026-04-14
CHILDREN ACETAMINOPHEN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by AARNA USA INC.. The most commonly reported adverse reactions for CHILDREN ACETAMINOPHEN include ABASIA, PAIN IN EXTREMITY. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CHILDREN ACETAMINOPHEN.
Out of 1 classified reports for CHILDREN ACETAMINOPHEN:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 2 FDA FAERS reports that mention CHILDREN ACETAMINOPHEN. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include ABASIA, PAIN IN EXTREMITY. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list AARNA USA INC. in connection with CHILDREN ACETAMINOPHEN. Always verify the specific product and NDC with your pharmacist.